Eylea hd (aflibercept) injection 8 mg approved by fda for treatment of wet age-related macular degeneration (wamd), diabetic macular edema (dme) and diabetic retinopathy (dr)

Approval based on the pivotal pulsar and photon trials in which eylea ® hd demonstrated clinically equivalent vision gains to eylea (aflibercept) injection 2 mg that were maintained with fewer injections
REGN Ratings Summary
REGN Quant Ranking